TYO:2395 Revenue

Shin Nippon Biomedical Laboratories had revenue of 9.73B JPY in the quarter ending December 31, 2024, with 59.46% growth. This brings the company's revenue in the last twelve months to 30.70B, up 14.97% year-over-year. In the fiscal year ending March 31, 2024, Shin Nippon Biomedical Laboratories had annual revenue of 26.45B with 5.42% growth.

Revenue (ttm)

30.70B

Revenue Growth

+14.97%

P/S Ratio

1.94

Revenue / Employee

21.07M

Employees

1,341

Market Cap

59.58B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2024	26.45B	1.36B	5.42%
Mar 31, 2023	25.09B	7.34B	41.37%
Mar 31, 2022	17.75B	2.64B	17.46%
Mar 31, 2021	15.11B	549.00M	3.77%
Mar 31, 2020	14.56B	-1.10B	-7.01%
Mar 31, 2019	Pro	Pro	Pro
Mar 31, 2018	Pro	Pro	Pro
Mar 31, 2017	Pro	Pro	Pro
Mar 31, 2016	Pro	Pro	Pro
Mar 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Chugai Pharmaceutical	1,170.61B
Daiichi Sankyo Company	1,795.99B
Takeda Pharmaceutical Company	4,579.02B
HOYA Corporation	837.44B
Otsuka Holdings	2,329.86B
Terumo	1,011.15B
Astellas Pharma	1,867.63B
Olympus	993.33B

Revenue Rankings